Zevra Therapeutics, Inc. · NASDAQ:ZVRA
Adage Capital Management, L.P. reported a 6.84% stake in Zevra Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 12, 2025
Adage Capital Management, L.P. reported a 6.84% stake in Zevra Therapeutics, Inc., 3,650,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G).
- Stake
- 6.84%
- Shares
- 3,650,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 6.84% | 3,650,000 |
| Robert Atchinson | 6.84% | 3,650,000 |
| Phillip Gross | 6.84% | 3,650,000 |
Source
Related
- Zevra Therapeutics, Inc.
- Adage Capital Management, L.P.
- Zevra Therapeutics, Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · Nov 13, 2025
- Form 4 · McFarlane Neil F. · Oct 13, 2026
- Form 4 · Thompson Rahsaan · Aug 17, 2026
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Form 4 · Watton Corey Michael · Aug 12, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026